1.
Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal...
by Matyas, Gary R
Vaccine, 18 July 2011, Vol.29(32), pp.5137-5144

2.
Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines
by Alving, Carl R
Expert Review of Vaccines, 01 June 2012, Vol.11(6), pp.733-744

3.
Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants
by Seth, Labdhi
Vaccine, 04 October 2017, Vol.35(41), pp.5448-5454

4.
Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013
by Genito, Christopher J
Vaccine, 05 July 2017, Vol.35(31), pp.3865-3874

5.
Design and selection of vaccine adjuvants: animal models and human trials
by Alving, Carl R
Vaccine, 2002, Vol.20, pp.S56-S64

6.
Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes
by White, Katherine
Vaccine, 1993, Vol.11(13), pp.1341-1346

7.
Selection of an adjuvant for vaccination with the malaria antigen, MSA-2
by Pye, David
Vaccine, 1997, Vol.15(9), pp.1017-1023

8.
